<DOC>
	<DOCNO>NCT01991418</DOCNO>
	<brief_summary>In pre-clinical study , find serum thioredoxin reductase activity harbour huge difference kind treatment , hypothesis serum activity thioredoxin reductase may warn marker excise non-small lung cancer , serum activity enzyme may elevate CT scan</brief_summary>
	<brief_title>Early Warning Study Serum Thioredoixn Reductase Activity Excised Non-small Cell Lung Cancers ( EWSOTRILC )</brief_title>
	<detailed_description>This cooperative research project Thoracic Surgery Department Medical Oncology department Affiliated Cancer Hospital xiangya School Medicine Central South University , State Key Laboratory Natural Medicine Biomimetic Drugs Perking University . The primary objective measure thioredoxin reductase activity blood stag ( Ⅰ~ⅢA ) non-small lung cancer , study warn relapse ability thioredoxin reductase blood . The secondary objective compare warn relapse activity blood thioredoxin reductase activity carcinoembryonic antigen ( CEA ) subject receive surgery . Blood collect subject surgery , 5 day surgery , every 3 month surgery till 2 year , every 6 month till 3 year , collect blood till tumor relapse subject stage ⅠA low risk ⅠB . Blood collect surgery , 5 day surgery , adjuvant chemotherapy , 2 circle adjuvant chemotherapy , every 3 month adjuvant chemotherapy till 2 year , every 6 month till 3 year , collect blood till tumor relapse subject high risk ⅠB~ⅢA , evaluation CT result every time collect blood sample .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Pathologically proven stag ( Ⅰ~ⅢA ) nonsmall cell lung cancer CT scan show resectable lung mass , fast pathology prove nonsmall cell lung cancer Receive surgery Thoracic Oncology department Affiliated Cancer Hospital xiangya School Medicine Central South University without contraindication surgery Tumor treatment naive（except surgery cervical cancer cutaneous squamous cell carcinoma 5 year before） Signed informed consent provide blood tissue study Patients receive antitumor treatment Patients contraindication surgery patient need adjuvant chemotherapy contraindication chemotherapy Pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>thioredoxin reductase</keyword>
	<keyword>carcina embryonic antigen</keyword>
</DOC>